US 11952374
Bicyclic compounds
granted A61KA61K31/519A61K31/5377
Quick answer
US patent 11952374 (Bicyclic compounds) held by Aligos Therapeutics, Inc. expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/519, A61K31/5377, A61K31/5395, A61K45/06